Projects per year
Personal profile
Personal profile
Bincy P. Abraham, MD, MS, is an associate professor of clinical medicine in the Academic Division of Gastroenterology and Hepatology at Houston Methodist – Weill Cornell in Houston, Texas.
Dr. Abraham earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. She is board certified in Internal medicine and Gastroenterology. Dr. Abraham is a member of the American Gastroenterological Association, American College of Gastroenterology, Crohn’s and Colitis Foundation, American Society of Gastrointestinal Endoscopy, and chair of the South Texas Chapter of the Crohn’s and Colitis Foundation Medical Advisory Committee.
Research interests
Dr. Abraham is a principal investigator and coinvestigator in several key clinical trials. As author or coauthor, Dr. Abraham’s work has been published in peer-reviewed medical journals including Clinical Gastroenterology and Hepatology, American Journal of Gastroenterology, and Inflammatory Bowel Diseases.
Research Area Keywords
- Digestive Disorders
Free-text keywords
- Crohn's disease
- Pregnancy & inflammatory bowel disease
- Transition of care in inflammatory bowel disease
- Ulcerative colitis
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Research Output
Antibiotics and probiotics in inflammatory bowel disease: When to use them?
Abraham, B. & Quigley, E. M. M., Jan 1 2020, In : Frontline Gastroenterology. 11, 1, p. 62-69 8 p.Research output: Contribution to journal › Review article
2
Scopus
citations
Erratum: Antibiotics and probiotics in inflammatory bowel disease: When to use them? (Frontline Gastroenterology (2020) 11 (62–69) DOI: 10.1136/flgastro-2018-101057)
Abraham, B. & Quigley, E. M. M., May 1 2020, In : Frontline Gastroenterology. 11, 3, p. E1Research output: Contribution to journal › Comment/debate
The microbiome and inflammatory bowel disease
Glassner, K. L., Abraham, B. P. & Quigley, E. M. M., Jan 2020, In : Journal of Allergy and Clinical Immunology. 145, 1, p. 16-27 12 p.Research output: Contribution to journal › Article
5
Scopus
citations
The use of combination biological or small molecule therapy in inflammatory bowel disease: A retrospective cohort study
Glassner, K., Oglat, A., Duran, A., Koduru, P., Perry, C., Wilhite, A. & Abraham, B. P., May 1 2020, In : Journal of Digestive Diseases. 21, 5, p. 264-271 8 p.Research output: Contribution to journal › Article
Nanotechnology in the treatment of inflammatory bowel disease
Giron, F., Pastó, A., Tasciotti, E. & Abraham, B. P., Dec 1 2019, In : Inflammatory bowel diseases. 25, 12, p. 1871-1880 10 p.Research output: Contribution to journal › Article
1
Scopus
citations